144 related articles for article (PubMed ID: 38364098)
21. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
[TBL] [Abstract][Full Text] [Related]
22. Candida auris PCR for high-throughput infection control screening.
Crawford LC; Kidd SE; Anninos TM; Turra M; Weldhagen GF
Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35927750
[TBL] [Abstract][Full Text] [Related]
23. Isolation of Candida auris in Clinical Specimens.
Yadav A; Singh A; Chowdhary A
Methods Mol Biol; 2022; 2517():3-20. PubMed ID: 35674941
[TBL] [Abstract][Full Text] [Related]
24. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
25. The environmental stress sensitivities of pathogenic Candida species, including Candida auris, and implications for their spread in the hospital setting.
Heaney H; Laing J; Paterson L; Walker AW; Gow NAR; Johnson EM; MacCallum DM; Brown AJP
Med Mycol; 2020 Aug; 58(6):744-755. PubMed ID: 31912151
[TBL] [Abstract][Full Text] [Related]
26.
White TC; Esquivel BD; Rouse Salcido EM; Schweiker AM; Dos Santos AR; Gade L; Petro E; KuKanich B; KuKanich KS
mBio; 2024 Feb; 15(2):e0308023. PubMed ID: 38193663
[No Abstract] [Full Text] [Related]
27. Tools and techniques to identify, study, and control Candida auris.
Carty J; Chowdhary A; Bernstein D; Thangamani S
PLoS Pathog; 2023 Oct; 19(10):e1011698. PubMed ID: 37856418
[TBL] [Abstract][Full Text] [Related]
28. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
29. The use of readily available laboratory tests for the identification of the emerging yeast Candida auris in Mexico.
González-Durán E; Contreras-Pérez CU; Caceres DH; Ríos-Rosas C; Piñón-Ortega JJ; Téllez-Saucedo MD; Marín-Suro ES; Wong-Arámbula CE; Moreno-Escobar EA; Ramírez-González JE; Ramírez-Barrios JG; Montes-Colima NA; Lockhart SR; Martínez-Montiel N; Martínez-Contreras RD; García-Ruíz P; Salazar-Sánchez MI; Hernández-Rivas L; López-Martínez I
Arch Microbiol; 2022 Sep; 204(9):592. PubMed ID: 36053373
[TBL] [Abstract][Full Text] [Related]
30. Host defense mechanisms against
Pechacek J; Lionakis MS
Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
[TBL] [Abstract][Full Text] [Related]
31. The adhesin SCF1 mediates Candida auris colonization.
Balakumar A; Bernstein D; Thangamani S
Trends Microbiol; 2024 Jan; 32(1):4-5. PubMed ID: 37951769
[TBL] [Abstract][Full Text] [Related]
32. A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen.
Das S; Singh S; Tawde Y; Chakrabarti A; Rudramurthy SM; Kaur H; Shankarnarayan SA; Ghosh A
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33208474
[TBL] [Abstract][Full Text] [Related]
33. Detection and Identification of Candida auris from Clinical Skin Swabs.
Kordalewska M; Perlin DS
Methods Mol Biol; 2022; 2542():245-256. PubMed ID: 36008670
[TBL] [Abstract][Full Text] [Related]
34. Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes.
Huang X; Welsh RM; Deming C; Proctor DM; Thomas PJ; ; Gussin GM; Huang SS; Kong HH; Bentz ML; Vallabhaneni S; Chiller T; Jackson BR; Forsberg K; Conlan S; Litvintseva AP; Segre JA
mSphere; 2021 Aug; 6(4):e0028721. PubMed ID: 34346704
[TBL] [Abstract][Full Text] [Related]
35. Colonization by Candida auris in critically ill patients: role of cutaneous and rectal localization during an outbreak.
Piatti G; Sartini M; Cusato C; Schito AM
J Hosp Infect; 2022 Feb; 120():85-89. PubMed ID: 34785292
[TBL] [Abstract][Full Text] [Related]
36. Liposomal formulation of a new antifungal hybrid compound provides protection against
Jaromin A; Zarnowski R; Markowski A; Zagórska A; Johnson CJ; Etezadi H; Kihara S; Mota-Santiago P; Nett JE; Boyd BJ; Andes DR
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0095523. PubMed ID: 38092678
[TBL] [Abstract][Full Text] [Related]
37. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
38. Evaluation of Eazyplex® LAMP test for fast Candida auris direct detection of colonized patients.
Hernández Felices FJ; Tormo Palop N; Salvador García C; Mulet Bayona JV; Guna Serrano MR; Gimeno Cardona C
Mycoses; 2024 Jan; 67(1):e13665. PubMed ID: 37860835
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of pathogenicity for the emerging fungus Candida auris.
Horton MV; Holt AM; Nett JE
PLoS Pathog; 2023 Dec; 19(12):e1011843. PubMed ID: 38127686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
